10 Mar 2015 14:56
10 March 2015
Collagen Solutions Plc
(the "Company" or the "Group")
Director/PDMR Shareholding
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, is pleased to announce that Mr. David E Evans, Chairman of the Company, has today purchased 250,000 ordinary shares in the Company at 8.65p per share.
Following this transaction, Mr. Evans total beneficial holding has increased to 12,888,730 ordinary shares representing 7.54 per cent of the issued ordinary share capital of the Company.
Enquiries:
Collagen Solutions Plc |
|
David Evans, Chairman | Tel: 07740 084 452 |
Stewart White, CEO | Tel: 0141 558 2008 |
|
|
Zeus Capital (Nominated Adviser and Broker) |
|
Ross Andrews / John Depasquale | Tel: 020 7533 7727 |
Alex Davies
Panmure Gordon & Co (Joint Broker) |
|
Robert Naylor (Corporate Finance) Maisie Atkinson (Corporate Broking) | Tel: 020 7886 2714Tel: 020 7886 2905 |
|
|
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com |
Mike Wort | Mob: 07900 608 002 |
Anna Dunphy | Mob: 07876 741 001 |
COS.L (COS)